Thomas Sciascia

Insider Reports History

Location
39 Old Ridgebury Rd. Suite 11, Danbury, CT
Signature
/s/ Christopher Galletta, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Sciascia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Trevi Therapeutics, Inc. Chief Scientific Officer Common Stock 221K $1.46M $6.60 Mar 25, 2025 Direct
Trevi Therapeutics, Inc. Chief Scientific Officer Performance Stock Option (right to buy) 92K May 31, 2025 Direct
Trevi Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 0 Mar 25, 2025 Direct

Insider Reports Filed by Thomas Sciascia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRVI Trevi Therapeutics, Inc. May 31, 2025 1 $0 4 Jun 3, 2025 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Mar 25, 2025 3 -$13.6K 4 Mar 26, 2025 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Mar 10, 2025 1 $0 4 Mar 12, 2025 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Feb 18, 2025 1 $0 4 Feb 20, 2025 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Aug 19, 2024 3 -$25.3K 4 Aug 21, 2024 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Aug 14, 2024 9 -$42.2K 4 Aug 16, 2024 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. May 29, 2024 3 -$6.12K 4 May 31, 2024 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Feb 15, 2024 1 $0 4 Feb 16, 2024 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Feb 16, 2023 1 $0 4 Feb 16, 2023 Chief Scientific Officer
TRVI Trevi Therapeutics, Inc. Sep 19, 2022 1 $0 4 Sep 19, 2022 Chief Medical Officer
TRVI Trevi Therapeutics, Inc. Jun 29, 2022 1 $0 4 Jul 1, 2022 Chief Medical Officer
TRVI Trevi Therapeutics, Inc. Feb 11, 2022 1 $0 4/A Jul 1, 2022 Chief Medical Officer